中药单体在子宫内膜癌中抗肿瘤机制的研究进展
Research Progress on the Anti-Tumor Mechanism of Traditional Chinese Medicine Monomers in Endometrial Cancer: A Review
DOI: 10.12677/ACM.2023.1381744, PDF,   
作者: 王甜慧, 赵子雪, 樊婷婷：黑龙江中医药大学第一临床医学院，黑龙江 哈尔滨
关键词: 子宫内膜癌；中药单体；作用机制；抗肿瘤；Endometrial Carcinoma； Traditional Chinese Medicine Monomers； Mechanism of Action； Antitumor
摘要: 子宫内膜癌凭借复杂的发病机制及不良的预后特征，成为严重危害女性身心健康的恶性肿瘤。随着科技的进步，针对子宫内膜癌的诊疗计划也在不断地被深入研讨，其中，中药单体在治疗角度方面表现出积极的抗肿瘤活性，主要依靠影响信号通路、炎性物质、细胞凋亡、侵袭和转移，甚至可作为辅助治疗的增敏剂发挥抑癌作用。回顾文献，总结整合了中药单体作用于子宫内膜癌的相关文献，并进行综述。以望为今后子宫内膜癌的诊治方案带来新思路。
Abstract: Endometrial cancer has become a malignant tumor that seriously endangers women’s physical and mental health due to its complex pathogenesis and poor prognosis. With the advancement of sci-ence and technology, the diagnosis and treatment plan for endometrial cancer is also constantly being studied in depth, among which, traditional Chinese medicine monomers show a positive an-ti-tumor activity in the treatment perspective, mainly relying on the influence of signaling pathways, inflammatory substances, apoptosis, invasion and metastasis, and even can be used as a sensitizer for adjuvant therapy to play a tumor inhibitory effect. This paper reviews the literature, summariz-es and integrates the important mechanisms of traditional Chinese medicine active substances act-ing on endometrial cancer, and hopes to bring new ideas for the diagnosis and treatment of endo-metrial cancer in the future.
文章引用：王甜慧, 赵子雪, 樊婷婷. 中药单体在子宫内膜癌中抗肿瘤机制的研究进展[J]. 临床医学进展, 2023, 13(8): 12448-12453. https://doi.org/10.12677/ACM.2023.1381744

参考文献

[1] Gu, B.X., Shang, X.G., Yan, M.Q., et al. (2021) Variations in Incidence and Mortality Rates of Endometrial Cancer at the Global, Regional, and National Levels, 1990-2019. Gynecologic Oncology, 161, 573-580. [Google Scholar] [CrossRef] [PubMed]
[2] Kailasam, A. and Langstraat, C. (2022) Contemporary Use of Hormonal Therapy in Endometrial Cancer: A Literature Review. Current Treatment Options in Oncology, 23, 1818-1828. [Google Scholar] [CrossRef] [PubMed]
[3] Guha, P., Sen, K., Chowdhury, P. and Mukherjee, D. (2023) Estrogen Receptors as Potential Therapeutic Target in Endometrial Cancer. Journal of Receptors and Signal Transduction, 43, 19-26. [Google Scholar] [CrossRef] [PubMed]
[4] 王晶, 袁江静, 王玉东. 2022欧洲肿瘤内科学会《子宫内膜癌临床实践指南》解读[J]. 中国实用妇科与产科杂志, 2022, 38(8): 827-829.
[5] Piccolo, L.M., Uski, A., Fer-nandes, J.D., et al. (2022) Practical MRI of Endometrial Neoplasms, Part 2: MRI and FIGO Staging. Contemporary Di-agnostic Radiology, 45, 1-7. [Google Scholar] [CrossRef] 
[6] Singh, P. and Lim, B. (2022) Targeting Apoptosis in Cancer. Current Oncology Reports, 24, 273-284. [Google Scholar] [CrossRef] [PubMed]
[7] 王风云, 李伟宏, 刘俊保. 槲皮素联合孕激素对人子宫内膜癌HEC-1-B细胞增殖、细胞周期及凋亡的影响[J]. 医药论坛杂志, 2021, 42(23): 1-6.
[8] 陈立平, 王柏欣, 王景涛, 等. 肉桂醛促进子宫内膜癌RL95-2细胞凋亡的机制[J]. 中山大学学报(医学版), 2019, 40(4): 540-545.
[9] Zdrojkowski, L., Jasinski, T., Ferreira-Dias, G., Pawliński, B. and Domino, M. (2023) The Role of NF-κB in Endometrial Diseases in Humans and Animals: A Review. International Journal of Molecular Sciences, 24, Article 2901. [Google Scholar] [CrossRef] [PubMed]
[10] Xu, H.Z., Gong, Z., Zhou, S.Y., et al. (2018) Liposomal Curcumin Targeting Endometrial Cancer through the NF-κB Pathway. Cellular Physiology and Biochemistry, 48, 569-582. [Google Scholar] [CrossRef] [PubMed]
[11] Li, Q., Zhang, J., Liang, Y., et al. (2018) Tanshinone I Exhibits Anticancer Effects in Human Endometrial Carcinoma HEC-1-A Cells via Mitochondrial Mediated Apoptosis, Cell Cycle Arrest and Inhibition of JAK/STAT Signalling Pathway. Journal of BUON, 23, 1092-1096.
[12] 范懿隽, 史于传, 李君, 等. 白藜芦醇抑制PI3K/AKT通路诱导子宫内膜癌Ishikawa细胞自噬的作用研究[J]. 安徽医科大学学报, 2022, 57(3): 361-365, 373.
[13] Lei, X., Guo, J., Wang, Y., et al. (2019) Inhibition of Endometrial Carcinoma by Kaempferol Is In-terceded through Apoptosis Induction, G2/M Phase Cell Cycle Arrest, Suppression of Cell Invasion and Upregulation of m-TOR/PI3K Signalling Pathway. Journal of BUON, 24, 1555-1561.
[14] Li, X.L., Zhang, X.X., Ma, R.H., et al. (2023) Integrated miRNA and mRNA Omics Reveal Dioscin Suppresses Migration and Invasion via MEK/ERK and JNK Sig-naling Pathways in Human Endometrial Carcinoma in vivo and in vitro. Journal of Ethnopharmacology, 303, Article ID: 116027. [Google Scholar] [CrossRef] [PubMed]
[15] 潘思影, 李伟宏, 田莉. 莪术油对人子宫内膜癌细胞HEC-1-B迁移及侵袭的影响[J]. 世界最新医学信息文摘, 2019, 19(25): 110-111.
[16] Berger, A.A., Dao, F. and Levine, D.A. (2021) Angiogenesis in Endometrial Carcinoma: Therapies and Biomarkers, Current Options, and Future Perspectives. Gynecologic Oncology, 160, 844-850. [Google Scholar] [CrossRef] [PubMed]
[17] 刘佳, 邓燕杰, 李秀娟, 等. 人参皂甙Rg3联合Lewis Y单克隆抗体对子宫内膜癌的治疗作用[J]. 中国妇幼保健, 2014, 29(14): 2248-2252.
[18] Domröse, C. and Mallmann, P. (2023) Adjuvante Therapie beim Endometriumkarzinom. Die Onkologie, 29, 421-425. [Google Scholar] [CrossRef] 
[19] Garg, V., Jayaraj, A.S. and Kumar, L. (2022) Novel Approaches for Treatment of Endometrial Carcinoma. Current Problems in Cancer, 46, Article ID: 100895. [Google Scholar] [CrossRef] [PubMed]
[20] Abreu, D.B. and Cernadas, J.R. (2022) Management of Adverse Reactions Induced by Chemotherapy Drugs. Current Opinion in Allergy and Clinical Immunology, 22, 221-225. [Google Scholar] [CrossRef] 
[21] Ghodousi, M., Karbasforooshan, H., Arabi, L. and Elyasi S., (2023) Silymarin as a Preventive or Therapeutic Measure for Chemotherapy and Radiotherapy-Induced Adverse Reac-tions: A Comprehensive Review of Preclinical and Clinical Data. European Journal of Clinical Pharmacology, 79, 15-38. [Google Scholar] [CrossRef] [PubMed]
[22] Tsai, Y.T., Kuo, P.H., Kuo, H.P., et al. (2021) Ganoderma tsu-gae Suppresses the Proliferation of Endometrial Carcinoma Cells via Akt Signaling Pathway. Environmental Toxicology, 36, 320-327. [Google Scholar] [CrossRef] [PubMed]
[23] Kandeil, M.A., Gomaa, S.B. and Mahmoud, M.O. (2020) The Effect of Some Natural Antioxidants against Cisplatin-Induced Neurotoxicity in Rats: Behavioral Testing. Heliyon, 6, E04708. [Google Scholar] [CrossRef] [PubMed]
[24] Wu, J.P., Li, Y.H., He, Q.J. and Yang, X.C. (2023) Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment. Molecules, 28, Arti-cle 1022. [Google Scholar] [CrossRef] [PubMed]
[25] Yu, L.N., Jin, Y., Song, M.J., Zhao, Y. and Zhang, H.Q. (2022) When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy. Pharmaceutics, 14, Article 1589. [Google Scholar] [CrossRef] [PubMed]
[26] Manchanda, S., Subashree, A.B., Renganathan, R., et al. (2023) Imaging Recommendations for Diagnosis, Staging, and Management of Uterine Cancer. Indian Journal of Medi-cal and Paediatric Oncology, 44, 110-118. [Google Scholar] [CrossRef] 
[27] Kommoss, S. (2023) Therapie des primären Endometriumkarzinoms auf der Grundlage molekularpathologischer Befunde. Die Gynäkologie, 56, 176-183. [Google Scholar] [CrossRef] 
[28] Fontenot, V.E. and Tewari, K. (2023) The Current Status of Immunotherapy in the Treatment of Primary Advanced and Recurrent Endometrial Cancer. Current Opinion in Obstetrics & Gynecology, 35, 34-42. [Google Scholar] [CrossRef] 
[29] Singla, R.K., Behzad, S., Khan, J., et al. (2022) Natural Ki-nase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies. Fron-tiers in Pharmacology, 13, Article 801733. [Google Scholar] [CrossRef] [PubMed]
[30] 李莉, 芦小珊, 辛佳纯, 等. 免疫与靶向治疗联用: 子宫内膜癌治疗新视角[J]. 国际妇产科学杂志, 2022, 49(1): 5-9.
[31] 刘绍颖, 范典, 郑博豪, 等. 子宫内膜癌靶向治疗新进展与前沿展望[J]. 中国癌症防治杂志, 2021, 13(2): 121-125.

为你推荐